EXPANSION OF INDICATIONS FOR BOTULINUM TOXIN TYPE A PREPARATION (ABOBOTULINUMTOXIN A): THE OPTIMAL APPROACH TO THE SELECTION OF TARGETED MUSCLES AND CALCULATION OF DOSES WITH THE SPASTIC FORMS OF INFANTILE CEREBRAL PALSY
- 作者: Kurenkov A.L1, Klochkova O.A1, Bursagova B.I1, Kuzenkova L.M1, Mamedyarov A.M1, Pack L.A1
-
隶属关系:
- National Medical Research Center for Children's Health
- 期: 编号 10 (2018)
- 页面: 46-51
- 栏目: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/295669
- DOI: https://doi.org/10.18565/pharmateca.2018.10.46-51
- ID: 295669
如何引用文章
详细
全文:
作者简介
A. Kurenkov
National Medical Research Center for Children's Health
Email: alkurenkov@gmail.com
MD, Neurologist, Leading Scientist
O. Klochkova
National Medical Research Center for Children's Health
B. Bursagova
National Medical Research Center for Children's Health
L. Kuzenkova
National Medical Research Center for Children's Health
A. Mamedyarov
National Medical Research Center for Children's Health
L. Pack
National Medical Research Center for Children's Health
参考
- Graham H.K., Rosenbaum P., Paneth N., et al. Cerebral palsy. Nat. Rev. Dis. Primers. 2016;2:15082. doi: 10.1038/nrdp.2015.82.
- Cerebral palsy: A Multidisciplinary Approach. 3rd edition (ed. C.P. Panteliadis). Cham: Springer, 2018. 358 p.
- Strobl W., Theologis T., Brunner R., et al. Best clinical practice in botulinum toxin treatment for children with cerebral palsy. Toxins (Basel). 2015;7(5):1629-48. doi: 10.3390/toxins7051629.
- Delgado M.R., Hirtz D., Aisen M., et al. Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2010;74(4):336-43. Doi.org/10.1212/WNL.0b013 e3181cbcd2f.
- Куренков А.Л., Клочкова О.А., Змановская В.А. и др. Первый Российский консенсус по применению многоуровневых инъекций Abobotulinumtoxin A при лечении спастических форм детского церебрального паралича. Журнал неврологии и психиатрии им. С.С. Корсакова. 2016;11(116):121-30. Doi. org/10.17116/jnevro20161 161 1 1 121-130.
- Baker R., Jasinski M., Maciag-Tymecka i., et al. Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebocontrolled, dose-ranging study. Dev. Med. Child Neurol. 2002;44(10):666-75.
- Kanovsky P., Bares M., Severa S., Richardson A.; Dysport Paediatric Limb Spasticity Study Group. Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy. Dev. Med. Child Neurol. 2009;51(6):436-45. doi: 10.1111/j.1469-8749.2008.03264.x.
- Клочкова O.A., Куренков А.Л., Каримова Х.М. и др. Многоуровневые инъекции ботулинического токсина типа А. (Абоботулотоксина) при лечении спастических форм детского церебрального паралича: ретроспективное исследование опыта 8 российских центров. Педиатрическая фармакология. 2016;13(3):259-69. doi: 10.15690/pf.v13i3.1576.
- Heinen F., Desloovere K., Schroeder A.S., et al. The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy. Eur. J. Paediatr. Neurol. 2010;14:45-66. Doi.Org/10.1016/J. Ejpn.2009.09.005.
- Love S.C., Novak I., Kentish M., et al.; Cerebral Palsy institute. Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement. Eur. J. Neurol. 2010;17(Suppl. 2):9-37. doi: 10.1111/j.1468-1331.2010.03126.x.
- Delgado M.R., Tilton A., Russman B., et al. Abobotulinumtoxin A for equinus foot deformity in cerebral palsy: a randomized controlled trial. Pediatrics. 2016;137(2):e20152830. doi: 10.1542/peds.2015-2830.
- Delgado M.R., Bonikowski M., Carranza J., et al. Safety and efficacy of repeat open-label AbobotulinumtoxinA treatment in pediatric cerebral palsy. J. Child Neurol. 2017;32(13):1058-64. doi: 10.1177/0883073817729918.
- Tilton A., Russman B., Aydin R.,etal.AbobotulinumtoxinA (Dysport®) improves function according to goal attainment in children with dynamic equinus due to cerebral palsy. J. Child Neurol. 2017;32(5):482-87. doi: 10.1177/0883073816686910.
- Mall V., Heinen F., Siebel A., et al. Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study. Dev. Med. Child Neurol. 2006;48(1):10-3. Doi: 10.1017/ S0012162206000041.
- Hägglund G., Wagner P Development of spasticity with age in a total population of children with cerebral palsy. BMC Musculoskelet Disord. 2008;9:150. doi: 10.1186/1471-2474-9-150.